Labuxtinib

DB21658ExperimentalSmall molecule

Labuxtinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Labuxtinib is a tyrosine kinase inhibitor. Labuxtinib has a monoisotopic molecular weight...

Mechanism: Pharmacologically active on Mast/stem cell growth factor receptor Kit
Curator reviewed
Formula / weight: C₂₀H₁₆FN₅O₂ · 377.379 g/mol (avg)

Resolves to

Compound

UNIIQNX4G754W6CAS1426449-01-5ChEMBLCHEMBL3962292ChEBI756013PubChem71280305

Structure

InChIKeyRHNJOZCVGSBEAG-KBPBESRZSA-NSMILESCC1=CC=C(C=C1NC(=O)C1=CN=C2C=CC=CN12)C1=NOC(=N1)[C@H]1C[C@@H]1F

Targets

P10721KIT

What you can answer from here — as of November 01, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Labuxtinib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account